Diligence memo · auto-generated · as of July 2, 2026

Wavetec Vision Systems Inc

Wavetec Vision Systems Inc looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Wavetec Vision Systems Inc operates in Other Health Care, based in Aliso Viejo.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Wavetec Vision Systems Inc has raised $100M in disclosed capital across 12 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $20M on 2009-01-29.

Most recent recorded round closed around 2014-02-28.

Valuation (modeled)modeled

Provath models Wavetec Vision Systems Inc at approximately $64M (range $6.8M–$247M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.14× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 6 months.

Last raise 12.3 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 3.9× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 96% of Other Health Care peers (5377 compared).

Modeled value ranks above 71% of those peers.

Closest niche peers: Drynachan, Llc, Vistria SHC Holdings, LLC, Ebh Holding Company, Inc., Orthopediatrics Corp, Assurerx Health, Inc.

Peoplefiled

16 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.